Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 1.00 |
| ▸ | MAX | P61244 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.53 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.52 |
| ▸ | NQO2 | P16083 | 8/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29737179 | 1.00 | MYC (1.00) | MYCMAXMAPTALDH1A1GAA | |
| SCHEMBL29337462 | 0.87 | MYC (0.77) | MYCMAXMAPTALDH1A1GAA | |
| SCHEMBL29337456 | 0.87 | MYC (0.77) | MYCMAXMAPTALDH1A1GAA | |
| SCHEMBL29337586 | 0.81 | MYC (0.67) | MYCMAXMAPTALDH1A1GAA | |
| SCHEMBL29337587 | 0.81 | MYC (0.67) | MYCMAXMAPTALDH1A1GAA | |
| SCHEMBL29337705 | 0.80 | MYC (0.65) | MYCMAXMAPTALDH1A1GAA | |
| SCHEMBL29337706 | 0.80 | MYC (0.65) | MYCMAXMAPTALDH1A1GAA | |
| SCHEMBL31391239 | 0.78 | MYC (0.63) | MYCMAXMAPTALDH1A1GAA | |
| SCHEMBL30705441 | 0.78 | MYC (0.63) | MYCMAXMAPTALDH1A1GAA | |
| SCHEMBL14328966 | 0.76 | MYC (0.61) | MYCMAXMAPTALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240243319-A1 | AQUEOUS ELECTROLYTE, SALTS USED THEREIN, AND REDOX FLOW BATTERY USING SAID AQUEOUS ELECTROLYTE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| US-10553799-B2 | Condensed cyclic compound and an organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-04 | — | — | US | disclosed |
| US-20170365794-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-12-21 | — | — | US | disclosed |
| US-20170365794-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-12-21 | — | — | US | disclosed |
| US-9522124-B2 | Methods for treating Alzheimer's disease | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2016-12-20 | — | — | US | disclosed |
| US-9522124-B2 | Methods for treating Alzheimer's disease | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2016-12-20 | — | — | US | disclosed |
| US-20150182477-A1 | Compositions and Methods for Treating Alzheimers Disease | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2015-07-02 | — | — | US | disclosed |
| US-20150182477-A1 | Compositions and Methods for Treating Alzheimers Disease | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2015-07-02 | — | — | US | disclosed |
| US-8980884-B2 | Methods for treating Alzheimer's disease | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2015-03-17 | — | — | US | disclosed |
| US-8980884-B2 | Methods for treating Alzheimer's disease | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2015-03-17 | — | — | US | disclosed |
| US-20120329789-A1 | COMPOSITIONS AND METHODS FOR TREATING ALZHEIMERS DISEASE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-12-27 | — | — | US | disclosed |
| US-20120329789-A1 | COMPOSITIONS AND METHODS FOR TREATING ALZHEIMERS DISEASE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120329789-A1 | COMPOSITIONS AND METHODS FOR TREATING ALZHEIMERS DISEASE | BACE1, APP, PSEN2 | MYC 2893/4885MAX 2413/4885MAPT 21/4885 |
| US-20170365794-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNA1 | MYC 1301/4885MAX 3882/4885MAPT 1538/4885 |
| US-20150182477-A1 | Compositions and Methods for Treating Alzheimers Disease | BACE1, APP, PSEN2 | MYC 2893/4885MAX 2413/4885MAPT 21/4885 |
| US-10553799-B2 | Condensed cyclic compound and an organic light-emitting device including the same | CRY1, CRY2, CCNA1 | MYC 1301/4885MAX 3882/4885MAPT 1538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.